Literature DB >> 23825905

Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue.

Mingxia Yan1, Hong Li, Fangyu Zhao, Lixing Zhang, Chao Ge, Ming Yao, Jinjun Li.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly human cancers, but it is very difficult to establish an animal model by using surgical specimens. In the present experiment, histologically intact fresh surgical specimens of HCC were subcutaneously transplanted in non-obese diabetic/severe combined immunodeficienccy (NOD/SCID) mice. The biological characteristics of the original and the corresponding transplanted tumors and cell lines were investigated. The results showed that 5 new animal models and 2 primary cell lines were successfully established from surgical specimens. Hematoxylin-eosin staining showed that xenografts retained major histological features of the original surgical specimens. The two new cell lines had been cultivated for 3 years and successively passaged for more than 100 passages in vitro. The morphological characteristics and biologic features of the two cell lines were genetically similar to the original tumor. The subcutaneous transplant animal models with histologically intact tumor tissue and primary cell lines could be useful for in vivo and in vitro testing of anti-cancer drugs and be ideal models to study various biologic features of HCC.

Entities:  

Keywords:  Animal model; hepatocellular carcinoma; subcutaneous transplantation; surgical specimens

Year:  2013        PMID: 23825905      PMCID: PMC3696707          DOI: 10.3978/j.issn.1000-9604.2013.05.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  24 in total

1.  Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection.

Authors:  H Saito; T Morizane; T Watanabe; T Kagawa; M N Iwabuchi; N Kumagai; Y Inagaki; K Tsuchimoto; M Tsuchiya
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

2.  Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.

Authors:  Lara Milane; Zhen-feng Duan; Mansoor Amiji
Journal:  Nanomedicine       Date:  2011-01-08       Impact factor: 5.307

3.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.

Authors:  Yan Li; Bo Tian; Jiong Yang; Lei Zhao; Xin Wu; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-05-14       Impact factor: 4.553

4.  Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo.

Authors:  Yanling Yang; Cheng Jin; Haimin Li; Yong He; Zhaohui Liu; Ling Bai; Kefeng Dou
Journal:  Exp Ther Med       Date:  2011-11-24       Impact factor: 2.447

5.  Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

Authors:  Iduna Fichtner; Jana Rolff; Richie Soong; Jens Hoffmann; Stefanie Hammer; Anette Sommer; Michael Becker; Johannes Merk
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

7.  Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.

Authors:  C R Leveille-Webster; I A Arias
Journal:  Clin Cancer Res       Date:  1996-04       Impact factor: 12.531

8.  Animal model for cholesteatoma induced in the gerbil: will the profiles of differentiation/growth-regulatory markers be similar to the clinical situation?

Authors:  Georges Choufani; Nicolas Roper; Carine Delbrouck; Sergio Hassid; Hans-Joachim Gabius
Journal:  Laryngoscope       Date:  2007-04       Impact factor: 3.325

9.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Authors:  Rui Liao; Han Wu; Yong Yi; Jia-Xing Wang; Xiao-Yan Cai; Hong-Wei He; Yun-Feng Cheng; Jian Zhou; Jia Fan; Jian Sun; Shuang-Jian Qiu
Journal:  J Exp Clin Cancer Res       Date:  2013-04-19
View more
  7 in total

1.  Derivate isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis.

Authors:  Lijuan Chen; Hua Tian; Meng Li; Chao Ge; Fangyu Zhao; Lixing Zhang; Hong Li; Junxi Liu; Tingpu Wang; Ming Yao; Jinjun Li
Journal:  Tumour Biol       Date:  2015-11-23

2.  Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient-Derived Xenograft Assays.

Authors:  Min Zhu; Lin Li; Tianshi Lu; Hyesun Yoo; Ji Zhu; Purva Gopal; Sam C Wang; Matthew R Porembka; Nicole E Rich; Sofia Kagan; Mobolaji Odewole; Veronica Renteria; Akbar K Waljee; Tao Wang; Amit G Singal; Adam C Yopp; Hao Zhu
Journal:  Hepatology       Date:  2020-09-02       Impact factor: 17.425

3.  Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Vinod C Malshe; Vaishali Pujari; Ajit Gorakshakar; Manisha Madkaikar; Kanjaksha Ghosh; Padma V Devarajan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE.

Authors:  Haoxuan Luo; Yan Chen; Baoguo Sun; Ting Xiang; Shijun Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

5.  A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression.

Authors:  Zhi-Ting Xu; Hong Ding; Tian-Tian Fu; Yu-Li Zhu; Wen-Ping Wang
Journal:  Med Sci Monit       Date:  2019-11-18

6.  Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.

Authors:  Xuanming Chen; Cheng Shen; Zhe Wei; Rui Zhang; Yongsheng Wang; Lili Jiang; Ke Chen; Shuang Qiu; Yuanli Zhang; Ting Zhang; Bin Chen; Yanjun Xu; Qiyi Feng; Jinxing Huang; Zhihui Zhong; Hongxia Li; Guowei Che; Kai Xiao
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

7.  PDXliver: a database of liver cancer patient derived xenograft mouse models.

Authors:  Sheng He; Bo Hu; Chao Li; Ping Lin; Wei-Guo Tang; Yun-Fan Sun; Fang-You-Min Feng; Wei Guo; Jia Li; Yang Xu; Qian-Lan Yao; Xin Zhang; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Yi-Xue Li; Hong Li; Xin-Rong Yang
Journal:  BMC Cancer       Date:  2018-05-09       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.